skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Recombinant Fowlpox-Prostate Specific Antigen Vaccine (Code C2675)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Recombinant Fowlpox-Prostate Specific Antigen Vaccine

Definition: A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04)

Display Name: Recombinant Fowlpox-Prostate Specific Antigen Vaccine

Label: Recombinant Fowlpox-Prostate Specific Antigen Vaccine

NCI Thesaurus Code: C2675 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1134640  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Fowlpox-PSA Vaccine
Recombinant Fowlpox-Prostate Specific Antigen
Recombinant Fowlpox-Prostate Specific Antigen Vaccine
Recombinant Fowlpox-PSA
Recombinant Fowlpox-PSA Vaccine

External Source Codes: 
NSC Code 694450 (see NCI DTP info)
PDQ Closed Trial Search ID 38629
PDQ Open Trial Search ID 38629 (check for NCI PDQ open clinical trial info)
UMLS CUI C1134640

Other Properties:
     Name Value (qualifiers indented underneath)
code C2675
Contributing_Source CTRP
Legacy_Concept_Name Fowlpox-PSA_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance
Semantic_Type Virus

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom